ID
13564
Beskrivning
Study of Clofarabine & Cytosine Arabinoside Therapy for Older Adults With Acute Myeloid Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT00081822
Länk
https://clinicaltrials.gov/show/NCT00081822
Nyckelord
Versioner (1)
- 2016-02-16 2016-02-16 -
Rättsinnehavare
CC BY-NC 3.0
Uppladdad den
16 februari 2016
DOI
För en begäran logga in.
Licens
Creative Commons BY-NC 3.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Acute Myeloid Leukemia NCT00081822
Eligibility Acute Myeloid Leukemia NCT00081822
- StudyEvent: Eligibility
Beskrivning
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Beskrivning
patients with pre-existing myelodysplastic syndrome, or with antecedent hematologic disorder of >3 months duration, will be excluded. those with concomitant myelodysplasia/trilineage dysplasia noted at the time of diagnosis of aml will be eligible 74
Datatyp
boolean
Alias
- UMLS CUI [1]
- C3463824
- UMLS CUI [2]
- C0018939
Beskrivning
have secondary aml (aml following chemotherapy or radiation therapy).
Datatyp
boolean
Alias
- UMLS CUI [1]
- C0280449
Beskrivning
have an active, uncontrolled systemic infection considered opportunistic, life threatening, or clinically significant at the time of treatment.
Datatyp
boolean
Alias
- UMLS CUI [1]
- C0009488
Beskrivning
have a psychiatric disorder(s) that would interfere with consent, study participation or follow-up.
Datatyp
boolean
Alias
- UMLS CUI [1,1]
- C0021430
- UMLS CUI [1,2]
- C0439801
- UMLS CUI [1,3]
- C0009488
Beskrivning
are receiving other chemotherapy or corticosteroids (unless the latter is administered at a low dose for pre-medication purposes or for the treatment of chronic conditions - e.g., rheumatoid arthritis).
Datatyp
boolean
Alias
- UMLS CUI [1]
- C0392920
- UMLS CUI [2]
- C0001617
Beskrivning
have received prior treatment for leukemia. patients who have received growth factors, cytokine support, leukapheresis, hydroxyurea, or cranial irradiation will be allowed but must discontinue treatment at least 24 hours prior to beginning treatment with clofarabine. if used, hydroxyurea must be discontinued 48 hours prior to the initiation of chemotherapy.
Datatyp
boolean
Alias
- UMLS CUI [1]
- C1514463
- UMLS CUI [2]
- C0018284
- UMLS CUI [3]
- C0199974
- UMLS CUI [4]
- C0023416
- UMLS CUI [5]
- C0020402
- UMLS CUI [6]
- C0079172
Beskrivning
have any other severe concurrent disease (severe coronary artery disease (nyha class >ii), significant neurological disorder, uncontrolled diabetes, etc.), which, in the judgment of the investigator, would make the patient inappropriate for entry into this study.
Datatyp
boolean
Alias
- UMLS CUI [1,1]
- C1321605
- UMLS CUI [1,2]
- C0439801
- UMLS CUI [1,3]
- C0009488
Beskrivning
have active central nervous system involvement with leukemia.
Datatyp
boolean
Alias
- UMLS CUI [1]
- C1332884
Beskrivning
other malignancy within the past year, with the exception of basal cell or non-metastatic squamous cell carcinoma of the skin
Datatyp
boolean
Alias
- UMLS CUI [1]
- C0006826
Similar models
Eligibility Acute Myeloid Leukemia NCT00081822
- StudyEvent: Eligibility
C0023487 (UMLS CUI [2])
C3688712 (UMLS CUI [3])
C1515708 (UMLS CUI [4])
C2825131 (UMLS CUI [5])
C0032961 (UMLS CUI [2])
C0700589 (UMLS CUI [3])
C1278039 (UMLS CUI [2])
C0201899 (UMLS CUI [3])
C0201836 (UMLS CUI [4])
C0018939 (UMLS CUI [2])
C0439801 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,3])
C0001617 (UMLS CUI [2])
C0018284 (UMLS CUI [2])
C0199974 (UMLS CUI [3])
C0023416 (UMLS CUI [4])
C0020402 (UMLS CUI [5])
C0079172 (UMLS CUI [6])
C0439801 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,3])